Comparison of methods for estimating the effect of salvage therapy in prostate cancer when treatment is given by indication

摘要

For patients who were previously treated for prostate cancer, salvage hormone therapy is frequently given when the longitudinal marker PSA begins to rise during follow-up. Because the treatment is given by indication, estimating the effect of the hormone therapy is challenging. In a previous paper, Kennedy et al (2010), we described two methods for estimating the treatment effect, called two-stage and sequential stratification. The two-stage method involved modeling the longitudinal and survival data. The sequential stratification method involves contrasts within matched sets of people, where each matched sets includes people who did and did not receive hormone therapy. In this paper we evaluate the properties of these two methods and compare and contrast them with the marginal structural model methodology. The marginal structural model methodology involves a weighted survival analysis, where the weights are derived from models for the time of hormone therapy. We highlight the different conditional and marginal interpretations of the quantities being estimated by the three methods. Using simulations, which mimic the prostate cancer setting, we evaluate bias, efficiency, accuracy of estimated standard errors and robustness to modeling assumptions. The results show differences between the methods in terms of the quantities being estimated and in efficiency. We also demonstrate how the results of a randomized trial of salvage hormone therapy are strongly influenced by the design of the study, and discuss how the findings from using the three methodologies can be used to infer the results of a trial.